Changes in haemostasis and inflammatory markers after mRNA BNT162b2 and vector Ad26.CoV2.S SARS-CoV-2 vaccination

Reported thromboembolic events after SARS-CoV-2 vaccinations are still raising concerns, predominantly in non-scientific population. The aim of our study was to investigate the differences between haemostasis and inflammatory markers in the subjects vaccinated with mRNA BNT162b2 and vector Ad26.CoV2.S vaccine.

Source: Thrombosis Research - June 13, 2023 Category: Hematology Authors: I. Ivanko, I. Ćelap, S. Margetić, D. Marijančević, J. Josipović, P. Gaćina Tags: Full Length Article Source Type: research